SYNLAB AG (DB:SYAB) acquired Sistemas Genomicos S.L. from Ascires Biomedical Group on January 7, 2021. SYNLAB expects to spend more than approximately €200 million on M&A in 2022. Ernst & Young acted as a financial and legal advisor to Ascires grupo biomédico. Valeriano Hernandez Abogados acted as legal advisor and KPMG acted due diligence provider of Ascires. Gómez-Acebo & Pombo acted as legal advisor of SYNLAB.

SYNLAB AG (DB:SYAB) completed the acquisition of Sistemas Genomicos S.L. from Ascires Biomedical Group for €43 million on January 7, 2021.